Results 151 to 160 of about 11,406 (228)

Cystic fibrosis-related diabetes in the era of modern treatment using CFTR modulators in pediatric patients-a systematic review. [PDF]

Front Pediatr
Pietrzykowska A, Darmoń J, Szymocha K, Donocik W, Tarasiewicz M, Stadnik J, Jarosz-Chobot P.   +6 more
europepmc   +1 more source

Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators. [PDF]

Biomolecules
Parisi GF, Papale M, Pecora G, Presti S, Tosto M, Mulé E, Ornato V, Aloisio D, Leonardi S.   +8 more
europepmc   +1 more source

Purinergic signalling in the subretinal space: a role in the communication between the retina and the RPE [PDF]

, 2007
Claire H. Mitchell, David Reigada
core   +1 more source

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor. [PDF]

Front Pharmacol, 2023
Tümmler B.
europepmc   +1 more source

Effects of CFTR Modulators on <i>Pseudomonas aeruginosa</i> Infections in Cystic Fibrosis. [PDF]

Infect Dis Rep
Pescaru CC, Crișan AF, Marițescu A, Cărunta V, Marc M, Dumitrache-Rujinski Ș, Laitin S, Oancea C.   +7 more
europepmc   +1 more source

Nutritional impact of CFTR modulators in children with cystic fibrosis. [PDF]

Front Pediatr, 2023
Gaschignard M, Beaufils F, Lussac-Sorton F, Gallet P, Clouzeau H, Menard J, Costanzo A, Nouard L, Delhaes L, Tetard C, Lamireau T, Fayon M, Bui S, Enaud R.   +13 more
europepmc   +1 more source

CFTR Modulators for the Treatment of Chronic Obstructive Pulmonary Disease: The Jury Is Still Out! [PDF]

Am J Respir Crit Care Med
Regard L, Burgel PR.
europepmc   +1 more source

Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]

Life (Basel)
Manioudaki S, Vasilieva L, Geladari E, Mani I, Athanassa Z, Elefsiniotis I, Hadziyannis E, Sevastianos V, Oikonomou A, Theophilou A, Diamantea F, Alexopoulou A.   +11 more
europepmc   +1 more source

Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis. [PDF]

EClinicalMedicine
Safeer V S M, Behl S, Vaidya PC, Tiwari P, Bharti SK, Nahan N, Kumar Sahu J, Bansal D.   +7 more
europepmc   +1 more source

Modeling Cystic Fibrosis Patient-Specific Responses to CFTR Modulators Using Human Induced Pluripotent Stem Cells. [PDF]

Am J Respir Crit Care Med
Kanagarajah KR, Wu MJM, Lam T, Quach HT, Salih R, Antonio K, Moraes TJ, Ratjen F, Bear CE, Wong AP.   +9 more
europepmc   +1 more source